TrueBridge (TBRG) Q2 2025: EBITDA Margin Guidance Rises to 18.5% as Offshore and AI Initiatives Take Hold
TrueBridge’s Q2 showcased margin expansion and disciplined execution, driven by offshore optimization and AI integration, even as revenue guidance was trimmed due to delayed deal ramps and client retention headwinds. Leadership’s focus on operational standardization and new India capabilities positions the company for improved scalability and retention in 2026, though near-term growth is muted by elongated implementation cycles and rural healthcare policy uncertainty.
Summary
- Margin Expansion Outpaces Revenue: Cost discipline and offshore productivity are driving EBITDA margin gains despite top-line softness.
- Operational Overhaul Targets Retention: Standardization and new India office aim to stabilize client churn and improve delivery quality.
- Longer-Term Scalability in Focus: AI investments and leadership hires set the stage for improved growth and efficiency in 2026.
Performance Analysis
TrueBridge delivered a quarter marked by operational leverage and margin expansion, with adjusted EBITDA margin rising to 16% and guidance for the full year moving to 18.5% at the midpoint. This improvement stems from cost optimization, resource management, and the benefits of global offshoring, particularly in the financial health segment. Notably, gross margins in both financial health and patient care segments improved YoY, with patient care reaching 62% as cost actions from prior years continued to flow through.
Revenue growth remained subdued, with total revenue essentially flat YoY after normalizing for the Centric product sunset, and financial health revenue representing 63% of the mix. Bookings momentum was evident, with $25.6 million in TCV bookings and a 10% YoY increase, but delayed revenue recognition from larger, upstream deals meant that some signed contracts will not contribute until 2026. Client attrition in the CBO (Central Business Office) subsegment weighed on revenue, with leadership highlighting both the challenges and a concrete plan to address retention through operational changes and new talent additions.
- Cost Structure Shift: Gross margin improvements and reduced opex (operating expenses) reflect success in offshoring and resource management initiatives.
- Bookings Quality vs. Timing: Larger, multi-hospital deals are growing but take longer to implement, deferring revenue ramp.
- Retention Drag: CBO client renewals lagged expectations, pulling down near-term revenue, though year-to-date renewal rates are improving sequentially.
Free cash flow conversion improved materially, with $5.5 million generated year-to-date, and leverage reduced to 2.4x, reflecting ongoing financial discipline. The company’s ability to drive margin gains and cash flow despite top-line pressures signals a maturing business model focused on long-term scalability.
Executive Commentary
"By reinforcing our focus on interoperability and modern data infrastructure, we're working to make real-time, secure patient data accessible anytime and anywhere it's needed... Our improving margin profile is a sign that we are on the right track."
Chris Fowler, President and Chief Executive Officer
"Our profitability profile continues to improve as we realize the efficiencies and leverage that are inherent in our business. The midpoint of our revised guidance reflects an adjusted EBITDA margin of approximately 18.5%, which is up 200 basis points compared to the previous year."
Vinay Bhasi, Chief Financial Officer
Strategic Positioning
1. Offshore Optimization and India Expansion
TrueBridge is doubling down on global delivery, pausing global hiring in Q2 to realign resources and now moving forward with plans for a physical India office in 2026. This shift aims to standardize workflows, boost productivity, and embed in-office training and accountability, with a focus on supporting the CBO and EBO (Extended Business Office) businesses. The company expects this to drive sustained improvements in client satisfaction and retention, addressing prior misalignment in its remote workforce model.
2. AI and Technology Differentiation
AI integration is emerging as a strategic lever, both internally and for clients. Internally, a new AI tool for patient care support is designed to standardize and accelerate client responses. Externally, the collaboration with Microsoft to embed Dragon Copilot into TrueBridge’s EHR (Electronic Health Record) solution positions the company as a tech-forward partner for rural and community hospitals, with the rollout expected in the fall. These moves signal intent to enhance care delivery and operational efficiency for clients.
3. Retention and Operational Standardization
Client retention, especially in the CBO subsegment, is now a top operational focus, with leadership acknowledging prior underperformance and laying out a multi-quarter plan for recovery. Steps include new leadership hires with deep RCM (Revenue Cycle Management) expertise, standardized processes to replace bespoke client workflows, and enhanced resource management tools. While patient care segment retention remains in the high 90s, CBO retention is in the low 90s but expected to recover as these changes take hold in 2026.
4. Bookings Mix and Deal Flow Evolution
Bookings are shifting toward larger, more complex deals, particularly with integrated Entrust solutions for multi-hospital systems. These deals validate TrueBridge’s value proposition but introduce longer implementation cycles, impacting near-term revenue recognition. Management is prioritizing relationship expansion strategies—starting with smaller wins, then growing wallet share—which supports long-term growth but requires patience as revenue lags bookings.
Key Considerations
This quarter’s narrative is shaped by proactive margin management, a willingness to address operational shortcomings, and a measured approach to technology investments. The company’s transition to a standardized, scalable operating model is a multi-quarter journey, with near-term headwinds but improving visibility into 2026 performance.
Key Considerations:
- Offshore Execution Risk: India office aims to resolve prior remote model gaps, but successful integration and cultural alignment will be critical.
- AI as Differentiator: Microsoft partnership and internal AI tools could drive both client stickiness and operational savings if adoption meets expectations.
- Retention Recovery Pace: CBO segment remains a drag until new processes and leadership translate into improved renewals and client wins.
- Policy and Macro Uncertainty: The passing of OB3 (One Big Beautiful Bill) introduces uncertainty for rural hospital budgets, which could slow contract signings in the near term.
Risks
Near-term revenue growth is constrained by client churn in financial health and delayed implementation of larger deals, while macro and policy changes such as OB3 create budget uncertainty for rural hospital clients. Execution on India expansion and operational standardization carries integration and change management risk. If retention does not recover as planned, or if AI and tech investments fail to deliver differentiation, margin gains could prove unsustainable.
Forward Outlook
For Q3 2025, TrueBridge guided to:
- Revenue of $85 to $87 million
- Adjusted EBITDA of $14 to $16 million
For full-year 2025, management adjusted guidance:
- Revenue of $345 to $350 million (lowered top end)
- Adjusted EBITDA of $62 to $67 million (raised range)
Management highlighted:
- Ongoing cost actions and offshoring efficiencies will support margin trajectory into Q4 and 2026.
- Revenue recognition from large deals and client retention recovery are expected to drive improved growth in 2026.
Takeaways
TrueBridge’s Q2 underscores the company’s ability to drive margin expansion and cash flow through disciplined cost management and operational transformation, even as near-term revenue growth is hampered by client churn and delayed deal ramps.
- Margin Expansion: Operational and offshore initiatives are yielding tangible EBITDA improvements, validating the company’s focus on efficiency and scalability.
- Retention and Execution: The multi-quarter plan to stabilize CBO retention, combined with leadership hires and process standardization, is essential for restoring growth momentum.
- 2026 Inflection Watch: Investors should monitor the pace of India office integration, AI adoption, and the impact of OB3 on rural hospital demand as key variables for next year’s growth and margin trajectory.
Conclusion
TrueBridge is making disciplined progress on its transformation agenda, with margin gains and bookings momentum providing evidence of a stronger business model. Execution on retention and standardized delivery will determine whether the company can translate these operational wins into sustainable top-line growth in 2026 and beyond.
Industry Read-Through
The margin expansion and offshore leverage at TrueBridge signal that healthcare IT and RCM providers can unlock profitability through disciplined resource management and global delivery, even in a challenging macro and policy environment. The shift toward larger, integrated deals with longer implementation cycles is likely to become more common as providers consolidate and seek comprehensive solutions, suggesting that revenue recognition delays may become a sector-wide feature. AI partnerships with major tech players are emerging as table stakes for differentiation, with adoption and integration speed likely to separate winners from laggards among healthcare technology vendors.